Oliceridine (TRV-130) fumarate is a μ- opioid receptor agonist with the potential for the treatment of acute severe pain. It is a functionally selective μ-opioid receptor agonist developed by Trevena Inc. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less β-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.

纯度：≥98%

CAS：1467617-09-9